GalChimia Media Backgrounder

Pharmaceutical companies throughout Europe contract with GalChimia for synthesis and development of drug candidates. The Spain-based custom synthesis company uses state-of-the-art technologies to deliver comprehensive synthesis, drug discovery research, process development and reaction optimization services.

GalChimia employs an array of advanced drug synthesis technologies, including automated microwave synthesis, parallel synthesis, high-pressure reactions, and automated chromatography. GalChimia was among the pioneers that successfully heat reactions with microwave chemistry to increase yields and reaction speeds. The CRO also uses automated preparative chiral HPLC to separate mirror-image pairs of molecules, called enantiomers, of which only one might be an effective potential therapy.

Pharmaceutical companies have started seeking smaller and higher quality combinatorial chemistry libraries, which are collections of functionally-related compounds for identifying drug candidates. GalChimia’s organic chemistry and parallel reaction expertise produce modern combinatorial chemistry libraries that more efficiently identify potential new therapies.

Since its inception in 2001, GalChimia has emerged as one of Spain’s most prominent biotechnology successes due to its highly technically qualified staff and ability to work directly with customers throughout their drug development process. More than 40 percent of GalChimia’s 26 scientific staff have PhDs in organic chemistry and have an average of 5 years of industry experience developing processes and addressing regulatory standards.

GalChimia will continue to incorporate new technologies and expand facilities as it develops more drug candidates with Europe’s top pharmaceutical companies.